HLB Therapeutics Co., Ltd. engages in the development and sale of vaccines and manufacture of electronic parts. It operates through the following business divisions: Vaccine, Electronics, and Bio division. The Vaccine business division engages in the wholesale of flu vaccines and other vaccines. The Electronics business division manufactures motors, pumps, and electronic components. The Bio business division develops ophthalmic disease treatment, skin wound treatment and glioblastoma treatment. The company was founded on June 7, 2000 and is headquartered in Seongnam-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company